Policy · 117th Congress
House report questions FDA’s approval of Alzheimer’s drug
House Democrats releases a report highlighting potential problems in the FDA's approval of Alzheimer's drug Aduhelm.
Search Roll Call
Search the Roll Call archive by keyword, date, Congress, section, or tags.
13 results for "(S)-1-hydroxy-(S)-2-methylhexane"
Congress · 117th Congress
Stopgap funding bill clears House; next stop is Biden’s desk
Joe Manchin III’s, D-W.Va.’s permitting legislation, was dropped in the Senate earlier this week.
Congress · 117th Congress
Steps from the court, lawmakers plot next moves on abortion
“The decision is also a reminder to the country that D.C.’s lack of statehood means D.C. is subject to the whims of Congress.
Policy · 117th Congress
Most Americans have COVID-19 antibodies as case numbers rise
Ron Wyden, D-Ore., Christopher S. Murphy, D-Conn., and Vice President Kamala Harris tested positive for COVID-19.
Underinvesting in Science = Undermining America’s Future
Underinvesting in Science = Undermining America's Future -
Congress · 117th Congress
Senate confirms Califf to become Biden’s FDA commissioner
Mike Rounds, R-S-D., changed his “no” vote to “present” to pair with Sen. Ben Ray Lujan, D-N.M, who would have voted in favor of the nomination.
Policy · 117th Congress
Patients’ groups, progressives square off over Medicare Alzheimer’s decision
Competing campaigns look to influence the debate over dramatically restricting coverage of a controversial treatment drug Aduhelm.
Congress · 117th Congress
Wyden probes FDA nominee’s views on accelerated drug approvals
Support from Wyden could be crucial to Robert Califf's FDA confirmation amid concerns from other Senate Democrats.
Policy · 117th Congress
Challenges could hinder pediatric COVID-19 vaccination effort
Julie Swann, a North Carolina State University professor who analyzes COVID-19’s impact on children, found that COVID-19 deaths and hospitalizations could rise, perhaps by as much as 20 percent,
Policy · 117th Congress
Some health experts confused about administration’s booster goal
The FDA examines booster shots for the Moderna and Johnson & Johnson vaccine, but experts remain confused about Biden's goals for boosters.
Policy · 117th Congress
FDA gives Pfizer’s COVID-19 vaccine its full approval
The FDA granted full approval to the Pfizer-BioNTech vaccine for COVID-19, aiming to persuade the hesitant that it is safe.
Policy · 117th Congress
Johnson & Johnson COVID-19 vaccine less effective than others but offers one-shot solution
Johnson & Johnson’s vaccine packages DNA in a gutted adenovirus, a type of virus that causes the common cold, to stop COVID-19’s spread.
Policy · 117th Congress
Biden inherits Trump’s unique health care agenda
An adverse Supreme Court ruling could throw a wrench into the president's plans to build on the 2010 health care law Trump sought to overturn